BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2013
View Archived Issues
Recombinant VWF-A2 polypeptide shows promise in LPS-induced DIC mouse model
Read More
Limited efficacy seen for ganetespib in patients with HCC
Read More
Peptide drug shows promise for skeletal dysplasia diseases related to FGFR3 gene mutations
Read More
Abbott updates recent pipeline progress
Read More
Amgen offers overview of fourth quarter 2012
Read More
Gilead Sciences presents novel voltage-gated sodium channel blockers
Read More
Sanofi presents new wound-healing agents
Read More
Bayer scientists patent new ALK-1 and SMAD 7 inhibitors
Read More
Model of hyperoxic injury shows adaptive changes against infection and ROS
Read More
Merck Serono and Feinstein Institute enter partnership
Read More
Galapagos receives grant for IBD research
Read More
Huabo Biopharm divulges novel bifunctional fusion proteins
Read More
The Technische Universitat Dresden patents novel antibodies for cancer
Read More
Gene-gene interactions associated with colorectal cancer risk identified
Read More
Vaxart begins phase I study of adjuvanted adenoviral-based influenza vaccine
Read More
Endocyte set to advance EC-1069 development
Read More
Adventrx begins pivotal phase III study of ANX-188
Read More
Medgenics begins phase I/II trial of Infradure tissue treatment in hepatitis C
Read More
Mesoblast cleared to begin study of mesenchymal precursor cells in patients with RA
Read More
Organovo and OHSU Knight Cancer Institute collaborate on in vitro cancer models
Read More
New collaboration on serological peptide markers for diagnosis of CFS
Read More
French ANSM to suspend marketing of Diane-35 and generics for acne
Read More
Dilaforette gains clearance in India to conduct phase II study of severe malaria treatment
Read More
Diamyd Medical to conduct new study of diabetes vaccine
Read More
Phase III ovarian cancer study of Opaxio continues following interim analysis
Read More
Encouraging results from phase III study of obinutuzumab in CLL
Read More